Results

Total Results: 2,204 records

Showing results for "drugs".

401. #05 DEPRESSION (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … available in generic form from several manufacturers, as well as in branded form, as Ketalar® (JHP Pharmaceuticals … CNS Drugs. 2012 Mar 1;26(3):189-204. … PMID: 14640353 http://www.cesar.umd.edu/cesar/drugs/ketamine.pdf http://www.cesar.umd.edu/cesar/drugs … Rochester (MI): JHP Pharmaceuticals, LLC; 2011 Jun. 4 p.

402. Comparative Effectiveness of Drug Therapy for Psoriatic Arthritis in Adults – An Update to the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric/research-protocol
     December 01, 2019 - Available therapies for PsA include corticosteroids, oral disease-modifying antirheumatic drugs (DMARDs … Finally, very little is known about the benefits or risks of these drugs in different patient subgroups … Simponi® Tocililizumab Actemra®, RoActemrai® Comparators: All key questions: all review drugs

403. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
     September 01, 2011 - Currently, nine atypical antipsychotic drugs have been approved by FDA: aripiprazole, asenapine, clozapine … These drugs have been used off-label (i.e., for indications not approved by FDA) for the treatment of … While it is legal for a physician to prescribe drugs in such a manner, it is illegal for the manufacturer … How do they compare within the class and with other drugs used for the conditions? … How do they compare within the class and with other drugs used for the conditions?

404. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - San Diego (CA): Amylin Pharmaceuticals, Inc.; 2010 Jun 15 [accessed 2011 Feb 22]. [3 p]. … Amylin Pharmaceuticals. … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2012 Feb 20]. [4 p]. … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27. 11 p. … Get drugs straight to the eye. [internet].

405. Acute Treatments for Episodic Migraine | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/migraine-treatments/protocol
     March 01, 2020 - However, simple analgesics including nonsteroidal anti-inflammatory drugs (NSAIDs) used on 15 or more … reason, the American Headache Society has explicitly stated that opioids and butalbital-containing drugs … therapy versus: (1) nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … effectiveness of nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … infusion, topical nonopioid abortive drug, including:  Acetaminophen Nonsteroidal anti-inflammatory drugs

406. EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
     January 09, 2020 - However, simple analgesics including 2 nonsteroidal anti-inflammatory drugs (NSAIDs) used … reason, the American Headache Society has explicitly stated that opioids and butalbital-containing drugs … therapy versus: 1) nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … effectiveness of nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … , topical nonopioid abortive drug, including: • Acetaminophen • Nonsteroidal anti-inflammatory drugs

407. Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Nosocomial Pneumonia | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/pneumonia-antibiotic-treatment/research-protocol
     December 01, 2019 - For drugs with a narrow therapeutic index, such as vancomycin and the aminoglycosides, the risk of toxicities … also reduce nephrotoxicity in patients who are receiving aggressive dosing, concurrent nephrotoxic drugs … discussion, a new KQ was added to examine the effect of using prolonged or continuous infusions of drugs … creatinine clearance, time above MIC, and ratio of AUC to MIC (see Table 1 below for drug classes and drugs … Relationship OR MIC OR AUC OR Microbial Sensitivity OR Time Kill Curve) Antibiotics (Terms for drugs

408. Improving Medication Safety in High Risk Medicare Beneficiaries Toolkit (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
     July 01, 2012 - In isolation, identifying specific drugs to avoid is not sufficient for improving safety. … Drugs 2009;69(4):393-406. 21. Touchette DR, Burns AL, Bough MA, et al. … Different brand name drugs have different Orange Book AB ratings, and generics vary in their combination … If so, with what drugs and what was the reaction? 2. What is your height? 3. … C4.6 C4.7 C4.8 C4.9 C4.10 Patient forgets to use/take drug Patient has concerns with drugs

409. Management of Insomnia Disorder in Adults: Current State of the Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
     August 01, 2017 - Food and Drug Administration (FDA) has approved several prescription drugs for insomnia, typically … Food and Drug Administration (FDA) for insomnia. d Other benzodiazepines include drugs approved by … the FDA for insomnia (estazolam, flurazepam, lorazepam, quazepam, and triazolam) and drugs not approved

410. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - trials comparing darbepoetin to epoetin showed no statistically significant difference between these drugs … trials comparing darbepoetin to epoetin showed no statistically significant difference between these drugs … trials comparing darbepoetin to epoetin showed no statistically significant difference between these drugs

411. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
     December 06, 2010 - Available therapies for RA include corticosteroids, oral disease-modifying antirheumatic drugs (DMARDs … Finally, very little is known about the benefits or risks of these drugs AMONG different patient subgroups … review did not include certolizumab pegol, golimumab, and tocilizumab (listed above), because these drugs … Golimumab Simponi® Tocililizumab Actemra®, RoActemrai® • Comparators: For all KQs: all review drugs

412. 1. Which patients benefit the most from MTM services? 1.1. Which factors, or combinations of factors, are most predictive of the clinical benefit of MTM services? 1.1.1. Disease factors (e.g., diabetes vs COPD ; multi-morbidity vs single… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-which-patients-benefit-the-most-from-mtm-services-11-which-factors-or-combinations-of-factors-are-most-predictive-of-the-clinical-benefit-of-mtm-services-111-disease-factors-eg-diabetes-vs-copd-multi-morbidity-vs-single-di
     November 01, 2017 - on medications, patient out-of-pocket expenditures on medications, or type of medication [high-risk drugs … yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to

413. S16 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s16.pdf
     October 01, 2007 - controlled trials (RCTs) remain the ac- cepted “gold standard” for determining the efficacy of new drugs … Follow-up and monitoring is designed to promote adherence to the drugs under study and to detect any … Drug coverage—Which bisphosphonate drugs should be included on a drug fomulary? … , quality of intervention Timing of intervention Cointerventions, quality of care Adherence (for drugs … Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute

414. S89 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s89.pdf
     October 01, 2007 - Rapid Cycle Analysis Team Background: Rare but serious adverse events associated with vac- cines or drugs … meningococcal vaccine, drug safety (Med Care 2007;45: S89–S95) Concerns about the safety of vaccines and drugs … the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) and, for drugs … In addition, because drugs treat specific conditions, the pool of users for a new medication is limited … early detection of potential adverse events after the introduction of new vaccines, and possibly new drugs

415. Who Uses Exenatide For Glucose Control in Diabetes Mellitus? A Retrospective Cohort Study of a New Therapy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-glucose-control/research
     January 01, 2020 - Exenatide, manufactured as Byetta by Amylin Pharmaceuticals, Inc. … Additionally, a separate, linkable file is available which includes pharmacy claims for prescription drugs … In Table 3 , we provide details about the other drugs for DM used by these patients. … Experts weigh in on promotion, prescription of off-label drugs. JAMA 2007;297:683-684.

416. Management of Insomnia Disorder in Adults: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/insomnia/clinician
     March 01, 2021 - Food and Drug Administration (FDA) has approved several prescription drugs for insomnia, typically for … d Other benzodiazepines include drugs approved by the FDA for insomnia (estazolam, flurazepam, lorazepam … , quazepam, and triazolam) and drugs not approved by the FDA for insomnia (alprazolam and clonazepam)

417. CARDIOVASCULAR (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Cambridge (MA): Aegerion Pharmaceuticals, Inc.; 2012 Dec. 12 p. … Cambridge (MA): Aegerion Pharmaceuticals, Inc.; 2013 Apr. 12 p.

418. Management of Infantile Epilepsies | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/management-infantile-epilepsy/research
     March 01, 2023 - about initiate the diet rated fewer seizures as their top priority (65-69%); however, need for fewer drugs … Although parents worry about both short and long term adverse effects from drugs, included studies only … However, without randomization, inferring efficacy for drugs, dietary, and surgical therapies is likely … For example, although many different drugs and combinations of drugs are currently used in this population … , we only identified evidence for five drugs of which only levetiracetam had evidence sufficient to conclude

419. Research White Paper Multinational Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - focused on the outcomes, effectiveness, comparative clinical effectiveness, and appropriateness of pharmaceuticals … Food and Drug Administration [FDA], Health Canada, Japanese Pharmaceuticals and Medical Devices Agency … http://www.fda.gov/downloads/Drugs/Drug Safety/ucm089809.pdf. Accessed January 10, 2017. 21. … http://www.fda.gov/downloads/Drugs/Guida nces/ucm073122.pdf. Accessed January 10, 2017. 37. … /downloads/Drugs/DrugSafety/ucm089809.pdf http://www.wma.net/en/30publications/10policies/b3/ http://

420. 8 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - most regulatory approvals, and the source of most advertising and other claims made on behalf of drugs … For example, a systematic review of nonsteroidal anti-inflammatory drugs (NSAIDs) found cyclo-oxygenase … Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs … Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis … Causality assessment of adverse reactions to drugs—I.